EPIVIR is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Viiv Healthcare Company. The primary component is Lamivudine.
| Product ID | 49702-205_26fa815c-95c8-4f8e-9ac4-06410de130d6 | 
| NDC | 49702-205 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | EPIVIR | 
| Generic Name | Lamivudine | 
| Dosage Form | Solution | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2010-10-04 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA020596 | 
| Labeler Name | ViiV Healthcare Company | 
| Substance Name | LAMIVUDINE | 
| Active Ingredient Strength | 10 mg/mL | 
| Pharm Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2010-10-04 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA020596 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | ML | 
| Marketing Start Date | 2010-10-04 | 
| Ingredient | Strength | 
|---|---|
| LAMIVUDINE | 10 mg/mL | 
| SPL SET ID: | 89226149-47fa-4f7d-bb1f-1aa7034486b8 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 0173-0662 | EPIVIR | lamivudine | 
| 0173-0663 | EPIVIR | lamivudine | 
| 21695-367 | EPIVIR | lamivudine | 
| 49702-203 | EPIVIR | lamivudine | 
| 49702-204 | EPIVIR | lamivudine | 
| 49702-205 | EPIVIR | lamivudine | 
| 50090-0550 | EPIVIR | lamivudine | 
| 53808-0245 | EPIVIR | EPIVIR | 
| 53808-0246 | EPIVIR | EPIVIR | 
| 0904-6583 | LAMIVUDINE | lamivudine | 
| 10135-605 | Lamivudine | Lamivudine | 
| 31722-001 | lamivudine | lamivudine | 
| 31722-752 | Lamivudine | Lamivudine | 
| 31722-753 | Lamivudine | Lamivudine | 
| 31722-754 | Lamivudine | Lamivudine | 
| 33342-001 | Lamivudine | Lamivudine | 
| 33342-002 | Lamivudine | Lamivudine | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  EPIVIR  78906783  3227835 Live/Registered | VIIV HEALTHCARE COMPANY 2006-06-13 | 
|  EPIVIR  74213040  1981308 Live/Registered | VIIV HEALTHCARE COMPANY 1991-10-11 |